Chest Pain, Undifferentiated

Undifferentiated chest pain means exactly what it says: a patient presenting with pain, pressure, tightness, burning, or discomfort in the chest whose cause has not yet been established. It is one of the most common reasons for an emergency department visit and one of the most common concerns raised directly to a pharmacist, and its differential spans essentially every organ system in the thorax and upper abdomen — several of which are immediately life-threatening if missed.^[1]

A prospective cohort of 1819 consecutive patients presenting with chest discomfort to 2 Canadian tertiary care emergency departments found that 21.9% had a confirmed diagnosis of acute coronary syndrome (13.2% acute myocardial infarction, 8.6% definite unstable angina) at 30 days — and, critically, that the then-standard unstructured, individualized approach to assessment missed 5.3% of these ACS cases while simultaneously holding the large majority of patients who did not have ACS for extended observation.^[2] That combination — a real, substantial minority with a life-threatening cause, and a real, measurable miss rate under unstructured assessment — is exactly why this chapter is built around a single, universal, conservative red-flag screen rather than clinical impression alone.

The pharmacist's role here is deliberately narrow: triage, not diagnosis. This chapter does not teach how to definitively distinguish angina from esophageal spasm at the bedside — no reliable bedside test does that. It teaches which features mean "call 911 now," which mean "refer urgently today," and the narrow, specific circumstance in which a patient's pain has already been characterized and investigated closely enough that reassurance and self-care are genuinely appropriate instead. Every other section of this chapter, and the flowcharts in Clinical Decision Algorithm especially, exist in service of that one triage decision.

Chest pain is deliberately organized here by organ system, because the pharmacist's task is pattern recognition across systems, not deep diagnosis within any one of them — each of the conditions below has its own dedicated chapter on this platform for full assessment and management once the emergency-vs-not decision has been made.

Risk factors here are organized by the serious condition they raise concern for, since the practical question at the point of contact is "does this patient's background raise or lower my index of suspicion for an emergency," not a single unified list.

• Cardiac risk factors (raise concern for ACS): age, smoking, diabetes, hypertension, dyslipidemia, family history of premature coronary artery disease, known coronary artery disease or prior MI/revascularization, chronic kidney disease, and cocaine or stimulant use.
• VTE/pulmonary embolism risk factors: recent surgery, hospitalization, or prolonged immobility; active malignancy; hormonal contraception or hormone replacement therapy; pregnancy and the postpartum period; obesity; and a personal or family history of venous thromboembolism.
• Aortic dissection risk factors: poorly controlled hypertension, a known connective tissue disorder (Marfan syndrome, vascular Ehlers-Danlos syndrome), bicuspid aortic valve, prior aortic surgery or instrumentation, and cocaine use — see the Aortic Dissection chapter for the full list.
• Pneumothorax risk factors: tall, thin body habitus in a young adult; smoking; known COPD or other underlying lung disease; and recent chest trauma or a thoracic procedure.
• Factors that should specifically raise suspicion despite a reassuring-seeming presentation: female sex, diabetes (autonomic neuropathy can blunt ischemic pain), and older age — all three are associated with atypical, less classic presentations of genuinely serious disease, discussed further in Special Populations.^[3]

What the pharmacist can realistically assess

A community pharmacist's assessment is, by design, a focused history and visible/observable findings only — onset, character, location, radiation, duration, triggers and relievers, associated symptoms, and the red-flag screen in the previous section. A community pharmacist cannot obtain a 12-lead ECG, troponin, or imaging, and should not attempt to substitute clinical impression for those tests when any red flag is present. A hospital or clinic-based pharmacist may have access to review these results once they exist, but ordering and interpreting them is outside this chapter's scope — the point of this chapter is to get the patient to the team who can.

What happens after referral

Once a patient with chest pain reaches an emergency department, the standard immediate workup is a 12-lead ECG within 10 minutes of arrival (the single most important initial test, since it determines whether a STEMI protocol is activated), troponin (a highly sensitive and specific marker of myocardial injury, though also elevated by pulmonary embolism, myocarditis, pericarditis, and other non-ACS causes), and further imaging (chest x-ray routinely; CT angiography or echocardiography as the specific differential dictates).^[1]

A 12-lead ECG showing acute anterior STEMI, with ST elevation colour-coded in orange and reciprocal ST depression in blue — exactly the kind of finding a "cannot miss" cardiac chest pain presentation is screened for once a patient reaches a monitored setting. (Public domain, Wikimedia Commons)

Risk stratification for suspected ACS (context, not a pharmacist task)

Once a patient reaches an emergency setting, suspected non-ST-elevation ACS is commonly risk-stratified using a validated tool such as the TIMI risk score, a 7-item point-sum estimating 14-day risk of death, MI, or urgent revascularization.^[4] It is presented here only so a pharmacist reviewing a chart understands what the number means — full antiplatelet, anticoagulant, and reperfusion management is covered in the dedicated Acute Coronary Syndromes chapter, not here.

Why response to a trial treatment is not diagnostic

Neither relief with sublingual nitroglycerin nor relief with an antacid reliably distinguishes cardiac from non-cardiac chest pain — esophageal spasm can respond to nitrates, and cardiac pain has occasionally been reported to improve after antacid administration. Treat a "positive" response to either as reassuring at most, never as proof the pain is benign, and never let it substitute for the red-flag screen in a first presentation.^[1]

• Apply the red-flag screen to every chest pain encounter, in every setting, before anything else.
• Act on any red flag within minutes — activate EMS immediately rather than after extended deliberation or a trial of self-care.
• Get every red-flag patient to emergency care by ambulance, not self-transport, so assessment and treatment can begin immediately and continue en route.
• Avoid under-triage — missing acute coronary syndrome, aortic dissection, pulmonary embolism, tension pneumothorax, esophageal rupture, or cardiac tamponade — since the harm of a missed emergency is far greater than the harm of an unnecessary emergency department visit.
• Avoid indiscriminate over-triage of pain that is genuinely, specifically, and recently confirmed as a benign recurrent pattern, which erodes patient trust and consumes emergency resources needed elsewhere.
• Reserve reassurance and self-care exclusively for the narrow circumstance defined in Choose Initial Treatment and Algorithm B — never as a default.
• Set explicit, specific return precautions for every patient who is not immediately referred.
• Route every patient who is escalated or diagnosed to the appropriate condition-specific chapter (Acute Coronary Syndromes, Aortic Dissection, Venous Thromboembolism, Community-Acquired Pneumonia, GERD) for full management.

• Positioning — have the patient sit or lie down in whichever position is most comfortable while red flags are assessed and while awaiting EMS if activated; do not have them stand, pace, or continue activity.
• Never let a red-flag patient self-transport — call an ambulance rather than having the patient or a family member drive to the emergency department, so assessment and treatment (and, if needed, resuscitation) can begin immediately rather than only on arrival.^[5]
• Stay with the patient until EMS arrives or the referral is otherwise handed off, monitoring for any change (worsening pain, new dyspnea, syncope, or hemodynamic change) that would itself be a red flag.
• Give a complete handoff to EMS or the receiving facility: onset and character of the pain, which red flag(s) prompted the call, relevant history and medications, and exactly what first-response treatment (nitroglycerin, ASA) was given and when.
• Document the encounter — what was assessed, what red-flag screen was applied, and what was advised — regardless of outcome, including for a patient who declines transport against advice.
• For a patient genuinely eligible for self-care (see Choose Initial Treatment): explicit activity/trigger modification specific to the confirmed pattern (avoiding the specific food/positional trigger for reflux-pattern pain; avoiding the specific movement/exertion trigger for musculoskeletal-pattern pain), plus clear, specific written return precautions restating every Algorithm A red flag before ending the encounter.

Women

Women are meaningfully more likely than men to present without classic chest pressure — instead reporting shortness of breath, pressure or pain in the lower chest or upper abdomen, dizziness, lightheadedness, fainting, upper back pressure, or extreme fatigue. Apply the same red-flag threshold regardless of how atypical the presentation sounds; atypical is not reassuring.^[3]

Older adults

Presentation is more often atypical and blunted — less pronounced pain, more often dyspnea, confusion, or general unwellness as the dominant complaint. Comorbidity burden and baseline risk are both higher in this group, which should raise, not lower, the index of suspicion for a vague presentation.

Diabetes

Autonomic neuropathy can blunt or entirely mask ischemic pain ("silent" ischemia), so a diabetic patient with only mild discomfort, or with dyspnea/fatigue/nausea as the dominant symptom instead of pain, deserves the same urgency as a classic presentation.

Pregnancy and the postpartum period

Physiologic dyspnea and reflux are both common in pregnancy, which can make a genuinely benign explanation seem likely — but this population also carries a higher risk of several serious causes: pregnancy is a recognized VTE risk factor; new hypertension with epigastric or right-upper-quadrant pain, headache, or visual changes raises concern for preeclampsia/HELLP syndrome (see the Preeclampsia chapter); peripartum cardiomyopathy can present with chest discomfort and dyspnea; and aortic dissection risk is elevated specifically in the third trimester and early postpartum period, especially with an underlying connective tissue disorder (see the Aortic Dissection chapter's Special Populations). Refer promptly rather than defaulting to a physiologic explanation.

Psychiatric history / panic disorder

A patient with an established panic disorder diagnosis can still have a genuine cardiac event — a known psychiatric history is never, by itself, grounds to skip the red-flag screen or to attribute new or different chest pain to anxiety without objective assessment.

Cocaine or stimulant use

Can cause coronary vasospasm and precipitate ACS even without underlying atherosclerosis, and independently raises aortic dissection risk through acute severe hypertension — treat any chest pain in this context with a low threshold for escalation.

Known coronary artery disease or prior MI

Any new or different pain pattern in this group — even if milder than the patient's prior infarct — is a red flag on its own; a lower threshold applies than in a patient with no cardiac history.

Stable, chronic angina previously characterized by a cardiologist

A patient with a formal diagnosis of stable angina, on an established anti-anginal regimen, whose pain today is unchanged from their well-characterized baseline pattern and responds to their usual nitroglycerin as expected, may be an appropriate candidate for the same-pattern self-care pathway in Choose Initial Treatment — but any change from that established baseline (more frequent, more severe, lower-threshold, or unrelieved by the usual dose of nitroglycerin) is itself a red flag requiring urgent reassessment, not a variant of the known pattern.^[6]

For every patient who is referred or for whom EMS was activated, the pharmacist's responsibility ends with a complete handoff (see Non-Pharmacologic Treatment) — ongoing monitoring and follow-up become the receiving team's responsibility.

For a patient genuinely eligible for reassurance and self-care: confirm they already have, or help arrange, follow-up with their own prescriber or primary care team, particularly if the "previously investigated" workup was some time ago or if self-care is being repeated for recurrent episodes. Restate the specific return precautions in plain language before ending the encounter — every Algorithm A red flag, plus "the self-care trial does not relieve the pain as expected" and "the pain changes in any way" — and confirm the patient (or a caregiver) can repeat them back before leaving.

Patient education is not a separate add-on here — it is the entire deliverable for a self-care encounter: what pattern was confirmed as benign, exactly what to try and for how long before it should have worked, and exactly what would mean "this is no longer the same pattern, call again or go to the emergency department." A patient who cannot repeat back the return precautions should not be discharged on a self-care plan alone.

1. Self-care trial (antacid, H2RA, PPI, acetaminophen, or NSAID) does not relieve the pain within the expected timeframe for that agent: stop self-care and treat as a new, undifferentiated presentation — return to the Algorithm A red-flag screen and refer. Do not extend the trial "a little longer" or add a second self-care agent on top of the first.
2. Pain resolves spontaneously after 911 has already been called: continue with the planned EMS/emergency department evaluation regardless — spontaneous resolution does not exclude a serious cause and is not a reason to cancel the call.
3. A patient with a prior negative cardiac or GI workup re-presents with a new or different feature (different location, new associated symptom, or any red flag): treat this as an entirely new presentation and apply the full Algorithm A screen — a prior negative workup for a different-sounding pain does not cover today's presentation.
4. Genuine uncertainty about whether the current pain matches a previously investigated pattern closely enough: default to referral. When in doubt, the rule in this chapter is to escalate, never to reassure.
5. A patient declines transport or referral despite an identified red flag: document the red flag, the recommendation given, and the decline clearly, and still provide explicit return precautions and encourage the patient to call 911 themselves if anything worsens.

• Anchoring on "it's probably just anxiety" or "it's probably just reflux" in a young or otherwise low-apparent-risk patient without a completed, documented prior workup specific to today's pain.
• Treating an improving or currently pain-free patient as automatically safe — resolution of pain does not exclude a serious cause and is not a reason to skip the red-flag screen.
• Letting a patient with any red flag drive themselves, or be driven by a family member, to the emergency department instead of calling an ambulance.
• Withholding ASA due to an unclear or assumed allergy without actually asking the patient directly.
• Delaying the 911 call to try a self-care measure first "to see if it helps" — the red-flag screen comes before any treatment trial, not after one.
• Treating relief with nitroglycerin or an antacid as diagnostic proof of a cardiac or GI cause respectively — esophageal spasm can respond to nitrates, and neither response reliably distinguishes cardiac from non-cardiac pain.^[1]
• Failing to re-screen a "known, chronic" pain pattern when it changes in frequency, severity, or trigger threshold — a changed pattern is a new presentation, not a variant of the old one.
• Under-recognizing atypical presentations in women, patients with diabetes, older adults, and pregnant/postpartum patients — atypical is not reassuring in any of these groups.
• Offering self-care advice for a first-ever, never-investigated episode of chest pain — the self-care pathway in this chapter requires a prior formal workup, not just the pharmacist's own clinical impression today.
• Stacking a second self-care agent on top of a first that has not worked, rather than stopping and escalating per Treatment Failure / Next Step.

How to use this table: This is a triage chapter, not a disease-specific management chapter. The first-response class below applies only while EMS is already en route for suspected cardiac chest pain; the self-care classes apply only after the strict eligibility criteria in Choose Initial Treatment and Algorithm B are confirmed — a prior formal workup for this exact pain pattern, unchanged today, with no new symptom or risk factor. Select any drug name to open its complete Pharmasist Drug Database page.

First-Response Therapy — Suspected Cardiac Chest Pain, While Awaiting Emergency Transport

Give while waiting for EMS, never instead of calling 911. Confirm no allergy/contraindication before ASA, and never initiate nitroglycerin in a patient with no prescription for it.

Self-Care Therapy — Confirmed Benign, Previously Investigated Reflux-Pattern Pain Only

Use only after full eligibility per Choose Initial Treatment/Algorithm B is confirmed. No relief within the expected timeframe, or any change in the pain, is a red flag — stop and refer rather than continuing or escalating the self-care agent.

Self-Care Therapy — Confirmed Benign, Previously Investigated Musculoskeletal-Pattern Pain Only

Use only after full eligibility per Choose Initial Treatment/Algorithm B is confirmed, and only for pain that is sharp, well-localized, and reproducible with palpation or movement.